American Cancer Society

Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection

Retrieved on: 
Thursday, February 15, 2024
ARK, Pura, SAN, American Cancer Society, Biotechnology, Roche, Valerio Vallania, Cancer, Liquid biopsy, RWD, Polaris Partners, Lung, Computational biology, Quest Diagnostics, Patient, Section 32, MRD, Disease, Machine learning, DGX, Investment, Smoker, Medical imaging

SOUTH SAN FRANCISCO, Calif., Feb. 15, 2024 /PRNewswire/ -- Freenome, a biotechnology company developing blood tests for early cancer detection, announced the addition of $254 million from new and existing investors. The funding enables Freenome to advance the pipeline of single-cancer and tailored multi-cancer early detection tests built on its multiomics platform.

Key Points: 
  • The funding enables Freenome to advance the pipeline of single-cancer and tailored multi-cancer early detection tests built on its multiomics platform.
  • Together, we share a commitment to addressing the pressing need for better cancer screening solutions as we drive to make early cancer detection more convenient, accessible and actionable for everyone," said Mike Nolan, chief executive officer of Freenome.
  • "With this financing, we are well positioned to realize the full potential of our platform in delivering tests for early cancer detection."
  • Enabling wider access to early cancer screening means helping patients receive timely information that can lead to better outcomes.

Kulur Group Names First Chief Communications & Kulture Officer to Help Write Its Next Chapter

Retrieved on: 
Wednesday, February 14, 2024
Marketing, Advertising, Communications, Digital Marketing, Content Marketing, Other Communications, Senior, American Cancer Society, Jackson State University, Multimedia, Journalism, Courage, ACS, Kulur, First, ELT, Creativity, Steph, Management

Kulur Group, a diverse-owned national challenger brand agency, announced today the appointment of Stephanie (Steph) Johnson as its first Chief Communications & Kulture Officer.

Key Points: 
  • Kulur Group, a diverse-owned national challenger brand agency, announced today the appointment of Stephanie (Steph) Johnson as its first Chief Communications & Kulture Officer.
  • View the full release here: https://www.businesswire.com/news/home/20240214697260/en/
    Kulur Group Names Stephanie Johnson as First Chief Communications & Kulture Officer to Help Write Its Next Chapter (Photo: Business Wire)
    As the Chief Communications & Kulture Officer at Kulur Group, Steph will join the Executive Leadership Team (ELT) and be the leading force behind Kulur's signature suite of Public Relations offerings.
  • Her energy is unrivaled, and her record of demonstrated excellence is second to none," says Nicholas Love, Kulur Group CEO.
  • Her role as Chief Communications & Kulture Officer will leverage her extensive experience in journalism, corporate communications, marketing, and public relations.

Shay Kerman of Urgent Care Solutions Named to the Denver Board of the American Cancer Society

Retrieved on: 
Wednesday, February 14, 2024
American Cancer Society, Education, Pain, Cancer, Volunteering, Death, Policy, Disease, Research

DENVER, Feb. 14, 2024 /PRNewswire/ -- Urgent Care Solutions is pleased to announce the appointment of Shay Kerman to the American Cancer Society's Board of Directors.

Key Points: 
  • DENVER, Feb. 14, 2024 /PRNewswire/ -- Urgent Care Solutions is pleased to announce the appointment of Shay Kerman to the American Cancer Society's Board of Directors.
  • Kerman serves as Owner of Urgent Care Solutions, dba as AFC Urgent Care, and Chief Executive Officer at StatLab Diagnostics.
  • With a commitment to providing quality care and improving the lives of Denver residents, Shay Kerman exemplifies the mission of the American Cancer Society, which strives to improve the lives of people with cancer and their families through advocacy, research, and patient support — ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer.
  • "I'm honored for the opportunity to serve on the Denver Board of the American Cancer Society to help fulfill its lifesaving mission across prevention, research, education, and support," said Kerman.

THIRD CHICKEN SALAD CHICK COMING TO COLUMBIA, SOUTH CAROLINA, WITH OPENING IN TRENHOLM PLAZA

Retrieved on: 
Wednesday, February 14, 2024
American Cancer Society, Restaurant, News, Family, Friends, Wi-Fi, FREE, Chicken Salad Chick, Sunset Boulevard, Friends and Family, Cancer, Poultry farming

ATLANTA, Feb. 14, 2024 /PRNewswire/ -- Chicken Salad Chick, the nation's only fast casual chicken salad restaurant concept, announced today its latest opening in Columbia, South Carolina. Located at 4840 Forest Drive in the Trenholm Plaza shopping center, this is the third Chicken Salad Chick to open in the market from owners Julie Beville and Michelle Singleton, who now own and operate an impressive 18 Chick restaurants overall. The community is invited to celebrate the grand opening on Tuesday, Feb. 27th; the first 100 guests in line will win free chicken salad for a year.

Key Points: 
  • -Fast casual concept celebrating grand opening on Feb. 27th with free chicken salad for a year-
    ATLANTA, Feb. 14, 2024 /PRNewswire/ -- Chicken Salad Chick , the nation's only fast casual chicken salad restaurant concept, announced today its latest opening in Columbia, South Carolina.
  • **
    Saturday, March 2 – The first 100 guests to purchase a Chick Meal receive a FREE commemorative Chicken Salad Chick Stadium Cup.
  • "Our team is thrilled to be opening a new Chicken Salad Chick on the east side of Columbia, and specifically in Trenholm Plaza," said Julie Beville.
  • Chicken Salad Chick in Trenholm Plaza will be open Monday – Saturday from 10:30 a.m. – 8 p.m. For more information, visit www.chickensaladchick.com .

BioXcel Therapeutics Receives FDA Fast Track Designation for BXCL701 for Treatment of Small Cell Neuroendocrine Prostate Cancer (SCNC)

Retrieved on: 
Monday, February 12, 2024
New product development, American Cancer Society, SCNC, Medicine, Prostate cancer, Intelligence, Adenocarcinoma, FDA, Food, CPI, Therapy, Patient, Microsatellite instability, Survival, Pharmaceutical industry

NEW HAVEN, Conn., Feb. 12, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced that the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of BXCL701 in combination with a CPI for the treatment of patients with metastatic small cell neuroendocrine prostate cancer (SCNC) with progression on chemotherapy and no evidence of microsatellite instability. The FDA grants Fast Track designation to facilitate the development and expedite the review of medicines to treat serious conditions, fill unmet medical needs, and bring promising medicines to patients more quickly. Therapies granted this designation are given the opportunity for more frequent interactions with the FDA, a rolling review, and potential eligibility for accelerated approval and priority review. 

Key Points: 
  • The FDA grants Fast Track designation to facilitate the development and expedite the review of medicines to treat serious conditions, fill unmet medical needs, and bring promising medicines to patients more quickly.
  • Therapies granted this designation are given the opportunity for more frequent interactions with the FDA, a rolling review, and potential eligibility for accelerated approval and priority review.
  • At the same time, it further validates the unique AI-based drug re-innovation approach that we used to discover this asset,” said Vimal Mehta, Ph.D., CEO of BioXcel Therapeutics.
  • “We are encouraged by the potential of BXCL701, which has demonstrated clinical proof of concept in both SCNC and adenocarcinoma.

Rita Case Wins Prestigious TIME Dealer of the Year Award

Retrieved on: 
Thursday, February 8, 2024
Professional Services, Philanthropy, General Automotive, Automotive, Small Business, Fund Raising, Other Transport, Foundation, Transport, Automotive Manufacturing, Other Automotive, Other Philanthropy, Manufacturing, HEART, Economics, Partnership, Holiday, Interim, Creativity, Timmerman, American Cancer Society, Woman, Federal Reserve Bank, Broward County Public Schools, Humanity, Nova Southeastern University, Cancer, Housing, Hyundai, Friends, Broward Health, BCPS, Cleveland Clinic, University of California, Davis, Boys & Girls Club, Ally Financial, Student, History, University, Sale, NADA, Organization, Trinity Health (Livonia, Michigan), TIME, Multimedia, American Heart Association, CPR, Community foundation, Acura, Boy, Female, National Automobile Dealers Association, Education, Freedom, Shoe, AHA, Baptist Health, Parent, Car dealership

Rita Case, president and CEO of Rick Case Automotive Group, the nation’s largest female owned and operated automotive dealer group in America, received the 55th Annual TIME Dealer of the Year Award, one of the automotive industry’s most prestigious and highest honors for a dealer.

Key Points: 
  • Rita Case, president and CEO of Rick Case Automotive Group, the nation’s largest female owned and operated automotive dealer group in America, received the 55th Annual TIME Dealer of the Year Award, one of the automotive industry’s most prestigious and highest honors for a dealer.
  • Rita is only the fifth woman to be named TIME Dealer of the Year.
  • TIME Dealer of the Year is the highest honor and most prestigious recognition an auto dealer can receive from the auto industry, and I am humbled and grateful for this award,” Rita said, as she received the award during the 107th Annual NADA Show in Las Vegas.
  • In 2023, the Community Foundation of Broward recognized Rita as a Community Builder and celebrated the establishment of the Rita & Rick Case Family Fund during a special ceremony.

Pacific Dental Services Marks American Heart Month with Expanded Focus on Oral Health Awareness

Retrieved on: 
Wednesday, February 7, 2024
Inflammation, Cholesterol, Ectopic pregnancy, NIH, American Heart, American Cancer Society, Research, Cardiovascular disease, PDS, CPR, Overalls, Patient, DNP, American Heart Month, Love, Dentistry, Periodontal disease, Diabetes, Education, Lung, Death, Stroke, Dementia, Alzheimer's disease, Health, Bangladesh Technical Education Board, Cancer, American Heart Association, Movement

IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ -- Pacific Dental Services® (PDS), a leading dental and medical support organization in the U.S., is recognizing American Heart Month throughout February with several initiatives that highlight the growing link between oral health and heart health.

Key Points: 
  • IRVINE, Calif., Feb. 7, 2024 /PRNewswire/ -- Pacific Dental Services® (PDS), a leading dental and medical support organization in the U.S., is recognizing American Heart Month throughout February with several initiatives that highlight the growing link between oral health and heart health.
  • "During American Heart Month our focus is on raising awareness about the importance of maintaining optimal oral health — a key contributor to improved heart health," said Stephen E. Thorne, Founder and CEO of Pacific Dental Services.
  • PDS-supported clinicians regularly educate patients about the link between oral health and overall health — also known as the Mouth-Body Connection® .
  • Throughout American Heart Month, PDS is conducting several initiatives to increase awareness about the connection between oral health and heart health, such as:
    Participating in National Wear Red Day to show support and raise awareness for heart health.

UBS Advisor Team Rimmel Mehaffey Pessy Wealth Consulting Group Named to Forbes Best-In-State Wealth Management Teams list

Retrieved on: 
Wednesday, February 7, 2024
Professional Services, Finance, Consulting, Asset Management, Banking, Personal Finance, Coalition, Family, Northern Tier (United States), History, Telephone, American Cancer Society, Research, Strategic planning, Friends, Pittsburgh Symphony Orchestra, Business, Light, Architecture, Miami University, Duquesne University, Investment, University, Sport, UBS, Golf

UBS Wealth Management USA today announced that Rimmel Mehaffey Pessy Wealth Consulting Group , an advisor team in the firm’s Pittsburgh, PA office, has been named to the Forbes Best-In-State Wealth Management Teams list for 2024.

Key Points: 
  • UBS Wealth Management USA today announced that Rimmel Mehaffey Pessy Wealth Consulting Group , an advisor team in the firm’s Pittsburgh, PA office, has been named to the Forbes Best-In-State Wealth Management Teams list for 2024.
  • This is the second consecutive year that the team has been ranked the top advisor team (#1) in Pennsylvania – West by Forbes.
  • “We’re proud of the team’s dedication, leadership, and excellence in helping each client pursue what matters most to them.”
    Rimmel Mehaffey Pessy Wealth Consulting Group is led by Financial Advisors Jim Rimmel and Dan Pessy.
  • Dan Pessy began his career at UBS in December 1999, joining the Rimmel Mehaffey Pessy Wealth Consulting Group in August 2000.

Prevencio and Emory Winship Cancer Institute AI-driven HART CVE Test Data Predicts Risk of Adverse Cardiovascular Effects Associated with Prostate Cancer Therapy

Retrieved on: 
Wednesday, February 7, 2024
Software, Research, Radiology, Oncology, Technology, Artificial Intelligence, Health Technology, Clinical Trials, Science, Cardiology, Other Science, Health, Skin cancer, Prostate cancer, ADT, American Cancer Society, Arrest, AUC, Patient, Diagnosis, Radiation, CVE, Control, Risk, Radiation therapy, Assistant professor, Stroke, Artificial intelligence

Researchers and clinicians from Emory Winship Cancer Institute collaborated to test their prostate cancer population.

Key Points: 
  • Researchers and clinicians from Emory Winship Cancer Institute collaborated to test their prostate cancer population.
  • “With cancer patients living longer, understanding the adverse cardiac effects due to cancer treatments, such as androgen deprivation therapy (ADT), is critical,” said Sagar Anil Patel, M.D., Assistant Professor, Department of Radiation Oncology and member of the Cancer and Control Research Program at Emory Winship Cancer Institute.
  • “It is rewarding to work with Dr. Patel and his team at Emory Winship Cancer Institute to demonstrate HART CVE’s usefulness in monitoring their prostate cancer patients.”
    This data adds to Prevencio’s previous HART CVE risk scoring collaboration with Memorial Sloan Kettering on lung radiation cancer patients.
  • Prostate cancer is the second most common cancer in men in the U.S., after skin cancer.

ProCure Addresses Projected Rise in Cancer Rates, Encourages Proactive Screening for Early Detection

Retrieved on: 
Tuesday, February 6, 2024
Proton, Knowledge, Genetic testing, Education, Proton therapy, American Cancer Society, News, Patient, Procurement, Health, Risk, Cancer, Colorectal cancer, Tobacco, Dietary supplement

Doctors at ProCure Proton Therapy Center say the news reinforces the need to stay updated on cancer screenings.

Key Points: 
  • Doctors at ProCure Proton Therapy Center say the news reinforces the need to stay updated on cancer screenings.
  • "Early detection is paramount in the battle against cancer," said Dr. Brian Chon, medical director at ProCure.
  • One of the more concerning areas of the report highlights the rise in cancer among younger patients.
  • Early detection of cancer enables patients to explore advanced treatment options, such as proton therapy.